News
NEWS
-
newsCelaid Therapeutics picked for NCC Venture Incubation Program.
-
financing
Capital procurement through third-party allotment of shares.
-
news
Joint research with the Institute of Medical Science, the University of Tokyo started.
-
newsArticle carried in UTokyo IPC’s Story.
-
newsCelaid Therapeutics article featured in Nikkei Biotechnology & Business.
-
newsCelaid Therapeutics featured in The Chemical Daily.
-
newsCelaid Therapeutics featured in DIAMOND SIGNAL.
-
newsCelaid Therapeutics featured in Tech Crunch.
-
news
Selected for UTokyo IPC 1st Round.